Literature DB >> 18055419

The role of the Wnt signaling pathway in osteoblast commitment and differentiation.

Maria P Yavropoulou1, John G Yovos.   

Abstract

Wnts are a large family of proteins that participate in an array of cellular biological processes such as embryogenesis, organogenesis and tumor formation. These proteins bind to membrane receptor complexes comprised of a frizzled (Fz) G-protein-coupled receptor and other membrane co-receptors forming molecular groups that initiate, at least, three different intracellular signaling cascades leading to nuclear generation of transcription factors which regulate various cellular events. These events result in selective cellular differentiation, reduction or inhibition of the apoptotic mechanisms or changes in the biologic behavior of various cell lines. During the last decade, canonical Wnt signaling has been shown to play a significant role in the control of osteoblastogenesis and bone formation. In several clinical cases, mutations have been found in the Wnt receptor complexes that are associated with changes in bone mineral density and fractures. Loss-of-function mutations in LRP5 receptors cause, osteoporosis-pseudoglioma syndrome, while gain-of-function mutations in the same group lead to high bone mass phenotypes. Furthermore, osteocytes secrete proteins such as sclerostin, which blocks the membrane complex activation by Wnt, resulting in inhibition of bone formation. Studies of knockout and transgenic mouse models for Wnt pathway components have demonstrated that canonical signaling regulates most aspects of osteoblast physiology including commitment, differentiation, bone matrix formation/mineralization and apoptosis as well as coupling to osteoclastogenesis and bone resorption. Future studies in this rapidly growing area of research can possibly lead to the identification of targets of pharmacological intervention useful in the management of osteoporosis. In the present review we summarized the current knowledge related to the various components of the Wnt signaling pathway, the ways they cooperate in inducing and directing transcriptional functions as well as the interacting points with the TGFbeta superfamily. We also outlined a probable working integrating model of the mechanism of bone formation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18055419     DOI: 10.14310/horm.2002.1111024

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  51 in total

Review 1.  The bone-marrow niche in MDS and MGUS: implications for AML and MM.

Authors:  Irene M Ghobrial; Alexandre Detappe; Kenneth C Anderson; David P Steensma
Journal:  Nat Rev Clin Oncol       Date:  2018-01-09       Impact factor: 66.675

2.  Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation.

Authors:  Vaclav Veverka; Alistair J Henry; Patrick M Slocombe; Andrew Ventom; Barbara Mulloy; Frederick W Muskett; Mariusz Muzylak; Kevin Greenslade; Adrian Moore; Li Zhang; Jianhua Gong; Xueming Qian; Chris Paszty; Richard J Taylor; Martyn K Robinson; Mark D Carr
Journal:  J Biol Chem       Date:  2009-02-10       Impact factor: 5.157

Review 3.  The molecular mechanism behind bone remodelling: a review.

Authors:  Peter Proff; Piero Römer
Journal:  Clin Oral Investig       Date:  2009-03-25       Impact factor: 3.573

4.  Osteogenic differentiation and gene expression profile of human dental follicle cells induced by human dental pulp cells.

Authors:  Su-Jin Park; Hyun-Sook Bae; Joo-Cheol Park
Journal:  J Mol Histol       Date:  2014-12-18       Impact factor: 2.611

5.  Epigenetic modifications and canonical wingless/int-1 class (WNT) signaling enable trans-differentiation of nonosteogenic cells into osteoblasts.

Authors:  Young-Dan Cho; Won-Joon Yoon; Woo-Jin Kim; Kyung-Mi Woo; Jeong-Hwa Baek; Gene Lee; Young Ku; Andre J van Wijnen; Hyun-Mo Ryoo
Journal:  J Biol Chem       Date:  2014-05-27       Impact factor: 5.157

6.  An integrative model of prostate cancer interaction with the bone microenvironment.

Authors:  A Farhat; D Jiang; D Cui; E T Keller; T L Jackson
Journal:  Math Biosci       Date:  2017-09-14       Impact factor: 2.144

7.  High cholesterol diet increases osteoporosis risk via inhibiting bone formation in rats.

Authors:  Li You; Zheng-yan Sheng; Chuan-ling Tang; Lin Chen; Ling Pan; Jin-yu Chen
Journal:  Acta Pharmacol Sin       Date:  2011-10-31       Impact factor: 6.150

8.  Petroleum ether extract of Cissus quadrangularis (Linn.) enhances bone marrow mesenchymal stem cell proliferation and facilitates osteoblastogenesis.

Authors:  Bhagath Kumar Potu; Kumar M R Bhat; Muddanna S Rao; Gopalan Kutty Nampurath; Mallikarjuna Rao Chamallamudi; Soubhagya Ranjan Nayak; Manjunatha S Muttigi
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

9.  Cytokine combination therapy prediction for bone remodeling in tissue engineering based on the intracellular signaling pathway.

Authors:  Xiaoqiang Sun; Jing Su; Jiguang Bao; Tao Peng; Le Zhang; Yuanyuan Zhang; Yunzhi Yang; Xiaobo Zhou
Journal:  Biomaterials       Date:  2012-08-19       Impact factor: 12.479

10.  Biomolecular basis of the role of diabetes mellitus in osteoporosis and bone fractures.

Authors:  Bipradas Roy
Journal:  World J Diabetes       Date:  2013-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.